Lactose India [LACTOSE] vs Innova Captab [INNOVACAP] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Lactose India Ltd. wins in 8 metrics, Innova Captab Ltd. wins in 11 metrics, with 0 ties. Innova Captab Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Lactose India Ltd. Innova Captab Ltd. Better
P/E Ratio (TTM) 30.45 31.20 Lactose India Ltd.
Price-to-Book Ratio 2.38 4.05 Lactose India Ltd.
Debt-to-Equity Ratio 86.78 32.95 Innova Captab Ltd.
PEG Ratio 0.21 1.33 Lactose India Ltd.
EV/EBITDA 12.54 20.49 Lactose India Ltd.
Profit Margin (TTM) 3.32% 8.85% Innova Captab Ltd.
Operating Margin (TTM) 4.45% 12.88% Innova Captab Ltd.
EBITDA Margin (TTM) 4.45% 12.88% Innova Captab Ltd.
Return on Equity 8.79% 13.37% Innova Captab Ltd.
Return on Assets (TTM) 3.87% 8.12% Innova Captab Ltd.
Free Cash Flow (TTM) $-146.70M $-1.09B Lactose India Ltd.
Dividend Yield N/A 0.30% N/A
1-Year Return 20.41% -3.19% Lactose India Ltd.
Price-to-Sales Ratio (TTM) 1.02 2.76 Lactose India Ltd.
Enterprise Value $1.98B $43.41B Innova Captab Ltd.
EV/Revenue Ratio 1.36 2.90 Lactose India Ltd.
Gross Profit Margin (TTM) 27.83% 35.19% Innova Captab Ltd.
Revenue per Share (TTM) $118 $262 Innova Captab Ltd.
Earnings per Share (Diluted) $3.86 $23.16 Innova Captab Ltd.
Beta (Stock Volatility) 0.39 -0.33 Innova Captab Ltd.

Lactose India Ltd. vs Innova Captab Ltd. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Lactose India Ltd.5.86%-6.31%-3.48%17.55%-7.12%3.88%
Innova Captab Ltd.-0.63%2.24%2.13%29.82%21.15%16.79%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Lactose India Ltd.20.41%127.85%280.87%63.03%1,621.05%19,298.31%
Innova Captab Ltd.-3.19%57.07%57.07%57.07%57.07%57.07%

Performance & Financial Health Analysis: Lactose India Ltd. vs Innova Captab Ltd.

MetricLACTOSEINNOVACAP
Market Information
Market Cap i₹1.48B₹41.43B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i9,346578,151
90 Day Avg. Volume i7,204217,693
Last Close₹114.65₹857.00
52 Week Range₹76.01 - ₹136.70₹622.00 - ₹1,020.70
% from 52W High-16.13%-16.04%
All-Time High₹247.40 (Dec 09, 2024)₹1,260.00 (Jan 06, 2025)
% from All-Time High-53.66%-31.98%
Growth Metrics
Quarterly Revenue Growth0.28%0.42%
Quarterly Earnings Growth1.42%0.23%
Financial Health
Profit Margin (TTM) i0.03%0.09%
Operating Margin (TTM) i0.04%0.13%
Return on Equity (TTM) i0.09%0.13%
Debt to Equity (MRQ) i86.7832.95
Cash & Liquidity
Book Value per Share (MRQ)₹49.43₹178.28
Cash per Share (MRQ)₹3.25₹10.22
Operating Cash Flow (TTM) i₹-49,118,000₹282.88M
Levered Free Cash Flow (TTM) i₹51.63M₹1.28B
Dividends
Last 12-Month Dividend Yield iN/A0.30%
Last 12-Month Dividend iN/A₹2.00

Valuation & Enterprise Metrics Analysis: Lactose India Ltd. vs Innova Captab Ltd.

MetricLACTOSE (Apr 24, 2026)INNOVACAP (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i30.4531.20
Forward P/E iN/A21.90
PEG Ratio i0.211.33
Price to Sales (TTM) i1.022.76
Price to Book (MRQ) i2.384.05
Market Capitalization
Market Capitalization i₹1.48B₹41.43B
Enterprise Value i₹1.98B₹43.41B
Enterprise Value Metrics
Enterprise to Revenue i1.362.90
Enterprise to EBITDA i12.5420.49
Risk & Other Metrics
Beta i0.39-0.33
Book Value per Share (MRQ) i₹49.43₹178.28

Financial Statements Comparison: Lactose India Ltd. vs Innova Captab Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricLACTOSE (2025)INNOVACAP (2025)
Revenue/Sales i1.16B12.34B
Cost of Goods Sold i772.10M8.38B
COGS % of Revenue i66.4%67.9%
Gross Profit i390.56M3.96B
Gross Margin i33.6%32.1%
Research & Development iN/AN/A
Operating Income (EBIT) i115.95M1.65B
Operating Margin i10.0%13.4%
EBITDA i175.41M2.00B
EBITDA Margin i15.1%16.2%
Pre-Tax Income i69.18M1.71B
Pre-Tax Income % of Revenue i5.9%13.9%
Income Tax i17.55M427.58M
Income Tax % of Revenue i1.5%3.5%
Net Income (Profit) i51.63M1.28B
Profit Margin i4.4%10.4%

Balance Sheet & Liquidity Metrics

MetricLACTOSE (2025)INNOVACAP (2025)
Cash & Equivalents i44.81M155.19M
Total Current Assets i573.26M7.03B
Total Current Assets % of Revenue i49.3%57.0%
Total Current Liabilities i448.90M3.53B
Total Current Liabilities % of Revenue i38.6%28.6%
Long-Term Debt i259.33M2.45B
Long-Term Debt % of Revenue i22.3%19.8%
Total Shareholders Equity i587.40M9.59B
Retained Earnings i260.03M4.53B
Retained Earnings % of Revenue i22.4%36.7%
Property, Plant & Equipment i12.74M442.93M

Cash Flow Statement Comparison

MetricLACTOSE (2025)INNOVACAP (2025)
Operating Cash Flow i-49.12M282.88M
Operating Cash Flow % of Revenue i-4.2%2.3%
Capital Expenditures i-139.17M-1.72B
Free Cash Flow i-146.70M-1.09B
FCF Margin i-12.6%-8.8%
Debt Repayment iN/A-114.03M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricLACTOSEINNOVACAP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i12.59M57.22M
Float Shares i5.19M15.91M
% Held by Insiders i58.73%72.19%
% Held by Institutions i0.00%19.22%
% Held by Public i41.27%8.59%

Dividend Analysis & Yield Comparison: Lactose India Ltd. vs Innova Captab Ltd.

MetricLACTOSEINNOVACAP
Last 12-Month Dividend iN/A₹2.00
Last 12-Month Dividend Yield iN/A0.30%
3-Year Avg Annual Dividend iN/A₹0.67
3-Year Avg Dividend Yield iN/A0.30%
3-Year Total Dividends iN/A₹2.00
Ex-Dividend DateN/AJan 30, 2026